SCHEMBL1164697

SCHEMBL1164697

COC(=O)c1ccc(O[C@H]2C[C@H]3CC[C@@H](C2)N3C(=O)O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
TSHR P16473 2/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
ATM Q13315 1/20 0.48
HSD17B10 Q99714 1/20 0.48
OPRK1 P41145 2/20 0.47
KCNH2 Q12809 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
EPHX2 P34913 4/20 0.45
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
CHRNA7 P36544 1/20 0.44
HTR3A P46098 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1164698 1.00 ALDH1A1 (0.48) ALDH1A1TSHRKDM4EGAAHPGD
SCHEMBL20958347 0.86 SLC6A2 (0.50) ALDH1A1OPRK1KCNH2SLC6A2SLC6A3
SCHEMBL20958345 0.86 SLC6A2 (0.50) ALDH1A1OPRK1KCNH2SLC6A2SLC6A3
SCHEMBL20958343 0.86 SLC6A2 (0.50) ALDH1A1OPRK1KCNH2SLC6A2SLC6A3
SCHEMBL12875510 0.84 CHRM2 (0.50) ALDH1A1TSHRKDM4EGAAHPGD
SCHEMBL20958273 0.82 NAAA (0.51) OPRK1KCNH2SLC6A2SLC6A3
SCHEMBL20958276 0.82 NAAA (0.51) OPRK1KCNH2SLC6A2SLC6A3
SCHEMBL20958274 0.82 NAAA (0.51) OPRK1KCNH2SLC6A2SLC6A3
SCHEMBL14860921 0.81 SLC6A2 (0.47) OPRK1KCNH2SLC6A2SLC6A3EPHX2
SCHEMBL20958387 0.81 SLC6A2 (0.63) OPRK1KCNH2SLC6A2SLC6A3EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011021645-A1 BICYCLIC UREA DERIVATIVE OR PHARMACOLOGICALLY PERMITTED SALT THEREOF 大日本住友製薬株式会社 (JP) 2011-02-24 WO disclosed